Table 1 Description and evaluation use case 1
Use case | 1. Impact of covid-19 pandemic on oncological treatment: retrospective analysis of data of the University Cancer Center Regensburg (UCC-R) in Germany |
|---|---|
Description | |
 Remark/objective | Current topic; across centers; large patient collective; no outcome-analysis |
 Study design | Only retrospective; no control-group |
 Data period | Past 3 years (2019–2021); all data since introduction of cancer registry law (2017) |
 Opportunities | Large number of cases for all relevant centers available in the database Research possibility of the system sufficient to get an overview |
 Risks/limitations | Several necessary parameters not available in database (e.g. diagnostics); diagnosis often not defined well (distinct point if time, clinical etc.) Fundamentals of documentation not always uniform across centers → Data quality varying throughout centers Oncological basis dataset not sufficient |
Evaluation | |
 Selection of software | No relevant negative aspects Adaptation of covered data items desirable |
 Database/data migration | No significant impairment through migration due to consideration of only more recent certification-relevant (primary) diagnoses → Already mainly standardized documentation in previous system |
 Data analysis process | Simple concept, few variables, clear timetable, only retrospective analysis → easy contemplation of proposal document Data extraction easy without connection of forms in the software Statistics (i.e. descriptive, correlations) with training materials practicable |